SPONSOR
Ali Rezai
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Opioid Use Disorder
Ali Rezai is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Opioid Use Disorder.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ali Rezai
How many clinical trials has Ali Rezai sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Ali Rezai, of which 1 are actively recruiting participants. These trials cover conditions including Opioid Use Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ali Rezai research focus on?
Ali Rezai clinical trials span Opioid Use Disorder. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Ali Rezai clinical trial?
To participate in a Ali Rezai trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ali Rezai trials with current recruitment status updated daily.
Clinical Trials by Ali Rezai
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology